Arbor Biotechnologies
At Arbor Biotechnologies, we develop genetic medicines through our discovery of programmable DNA editors to enable curative outcomes for patients.
$74M Series B+ ·
Led by TCG Crossover · Source: startupintros.com
Total raised: $289M across 2 sourced rounds
All 2 rounds ↓Signals
Arbor Biotechnologies | 165 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $74M | startupintros.com | ||
| Series B+ | $215M | finance.yahoo.com |
Timeline
- X account created
- Website created
Founders and team
DS
DW
FZ
WY
Winston Yan Arbor Co-founderDS
Devyn Smith CEOBK
Brent Kievit-Kylar Associate Director, Software EngineeringDH
Donald Haut Chief Business OfficerLA
Lee Ann Marchionna Chief People OfficerPS
Pam Stetkiewicz Chief Operating Officer
Acquisitions
| Acquired company | Price | Announced |
|---|---|---|
| SSerendipity Biosciences | Not disclosed publicly | Date not given |
Investors
AAberdeen
AARCH Venture Partners
AArrowMark Partners
DDeep Track Capital
KKerna Ventures
PPartners Investment
PPiper Heartland Healthcare Capital
QQatar Investment Authority
RRevelation Partners
RRidgeback CapitalSS32
SSurveyor Capital
TT. Rowe Price
TTao Capital
TTCG Crossoverlead investor
TTekla Capital Management
TTemaseklead investor
VVertex Pharmaceuticals
WWoodline Partners
Companies like Arbor Biotechnologies
SSailie BioSeed · Jul 2026
AAlloy Therapeutics$40M Series B+ · Apr 2026
WWaiv$33M Series A · Apr 2026SSoufflé Therapeutics$135M Series B+ · Oct 2026
FFinalDosePre Seed · Jun 2026
EEstuary Biotherapeutics$103M Series A · Oct 2026
Other companies backed by TCG Crossover
SSoufflé Therapeutics$135M Series B+ · Oct 2026
TTriGemX Bio$94M · Oct 2026
VVaderis Therapeutics$152M Series B+ · Aug 2026
CCorxel$287M Series B+ · Jan 2026MMirador Therapeutics$250M Series B+ · Jan 2026
SSynthekine$100M Series B+ · Jan 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/arbor-biotechnologies (get a free API key).